Skip to content

Oscar Health OSCR Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)

Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years) at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH

Other financials

Income statement

See full
Revenue$4.6B+52.6%
Operating income$704.1M+137%
Net income$679.0M+147%
EPS (diluted)$2.07+125%

Balance sheet

See full
Cash & equivalents$4.8B+114%
Total debt$430.9M+43.7%
Total equity$1.7B+24.8%
Total assets$9.3B+59.0%

Cash flow

See full
Operating cash flow$2.6B+198%
CapEx$8.8M-2.6%
Free cash flow$2.6B+200%

Valuation

See full
Market cap$8.56B+4.0%
Enterprise value$4.16B-174%
P/S0.6×-0.2×

Profitability

See full
Operating margin0.1%
Net margin-0.3%
FCF margin-8.2%

Returns & leverage

See full
Return on equity-2.6%
Debt / equity0.3×0.0×
Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost.

The official record: Oscar Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oscar Health's available-for-sale debt securities - fair value (maturing 1 to 5 years).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oscar Health's available-for-sale debt securities - fair value (maturing 1 to 5 years)?
Oscar Health (OSCR) reported available-for-sale debt securities - fair value (maturing 1 to 5 years) of $1.17B in Q1 2026.
How has Oscar Health's available-for-sale debt securities - fair value (maturing 1 to 5 years) changed year-over-year?
Oscar Health's available-for-sale debt securities - fair value (maturing 1 to 5 years) decreased by 35.3% year-over-year, from $1.81B to $1.17B.
What is the long-term trend for Oscar Health's available-for-sale debt securities - fair value (maturing 1 to 5 years)?
Over 2 years (2023 to 2025), Oscar Health's available-for-sale debt securities - fair value (maturing 1 to 5 years) has grown at a 94.4% compound annual growth rate (CAGR), from $363.17M to $1.37B.